Reports of burst balloons with the Sapien 3 Ultra heart valve have resulted in an urgent safety notice from the manufacturer and a Canadian recall of the system.

Nearly two-thirds of high-risk patients prescribed PCSK9 inhibitors to lower their risk of familial hypercholesterolemia and ASCVD are rejected coverage for the drugs by their health insurers, a new study alleges.

Researchers in Australia are in the process of converting a deadly local spider’s venom into a drug that could be used to reduce heart damage after an MI.

The FDA on July 15 approved Sun Pharmaceutical Industries’ sprinkle formulation of rosuvastatin, an alternative to traditional lipid-lowerers for patients who have difficulty swallowing.

The University of Chicago has agreed to pay $2.6 million to settle a malpractice lawsuit claiming the actions of its cardiology staff in July 2014 led to the untimely death of a 61-year-old heart patient.

Medtronic and Viz.ai, an AI-driven tech company, have joined forces to promote the adoption of imaging software that could drastically cut the time it takes physicians to identify suspected large vessel occlusion.

Heart patients exposed to phthalates—a group of chemicals used as plasticizers in the manufacture of plastic medical products—during invasive procedures may be at risk for serious electrophysiological abnormalities, according to a new study.

Toward the end of June, around a dozen American diabetics took an 817-mile caravan ride from Minneapolis to London, Ontario, in an effort to obtain more affordable insulin, CBS News reports. It was the second caravan in two months to make the trip.

A study out of the U.K. has found that, after the nation’s Food Standards Agency relaxed its sodium content regulations in 2011, Brits saw a simultaneous—and related—rise in cases of cardiovascular disease and stomach cancer.

A study published July 17 in the Journal of the American College of Cardiology has revealed a strong link between cancer and takotsubo cardiomyopathy, or “broken heart syndrome.”